Literature DB >> 30228505

Cystic Fibrosis Related Diabetes: a Unique Challenge in Diabetes Care.

Marina Litvin1, Schola Nwachukwu2.   

Abstract

Cystic Fibrosis (CF) is a common autosomal recessive disease that affects multiple organs due to a defect in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR). This transporter is present in various organs and tissues, including the airway epithelium, sinuses, pancreas, intestine, biliary tree, the vas deferens, and the sweat ducts, making CF a multi-system disease1. As CF patients are living longer, pancreatic function declines and diabetes emerges, further complicating the nutritional status and care of these patients.

Entities:  

Year:  2016        PMID: 30228505      PMCID: PMC6139848     

Source DB:  PubMed          Journal:  Mo Med        ISSN: 0026-6620


  53 in total

1.  Factors associated with a shorter time until the next pulmonary exacerbation in adult patients with cystic fibrosis.

Authors:  Iara Maria Sequeiros; Nabil Jarad
Journal:  Chron Respir Dis       Date:  2012-02       Impact factor: 2.444

2.  Glucose tolerance in cystic fibrosis.

Authors:  S Lanng; B Thorsteinsson; G Erichsen; J Nerup; C Koch
Journal:  Arch Dis Child       Date:  1991-05       Impact factor: 3.791

Review 3.  Cystic fibrosis-related diabetes: a distinct condition.

Authors:  Marta Cano Megías; Olga González Albarrán
Journal:  Endocrinol Nutr       Date:  2014-08-21

4.  Reduced levels of active GLP-1 in patients with cystic fibrosis with and without diabetes mellitus.

Authors:  Magnus Hillman; Leif Eriksson; Lena Mared; Karin Helgesson; Mona Landin-Olsson
Journal:  J Cyst Fibros       Date:  2011-12-03       Impact factor: 5.482

Review 5.  Epidemiology of Cystic Fibrosis.

Authors:  Kimberly A Spoonhower; Pamela B Davis
Journal:  Clin Chest Med       Date:  2016-03       Impact factor: 2.878

6.  Identification of insulin secretory defects and insulin resistance during oral glucose tolerance test in a cohort of cystic fibrosis patients.

Authors:  A Battezzati; A Mari; L Zazzeron; G Alicandro; L Claut; P M Battezzati; C Colombo
Journal:  Eur J Endocrinol       Date:  2011-04-18       Impact factor: 6.664

Review 7.  Nonclassic cystic fibrosis and CFTR-related diseases.

Authors:  Michael P Boyle
Journal:  Curr Opin Pulm Med       Date:  2003-11       Impact factor: 3.155

8.  Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis.

Authors:  Drucy Borowitz; Karen A Robinson; Margaret Rosenfeld; Stephanie D Davis; Kathryn A Sabadosa; Stephanie L Spear; Suzanne H Michel; Richard B Parad; Terry B White; Philip M Farrell; Bruce C Marshall; Frank J Accurso
Journal:  J Pediatr       Date:  2009-12       Impact factor: 4.406

9.  Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung.

Authors:  Alejandro A Pezzulo; Xiao Xiao Tang; Mark J Hoegger; Mahmoud H Abou Alaiwa; Shyam Ramachandran; Thomas O Moninger; Phillip H Karp; Christine L Wohlford-Lenane; Henk P Haagsman; Martin van Eijk; Botond Bánfi; Alexander R Horswill; David A Stoltz; Paul B McCray; Michael J Welsh; Joseph Zabner
Journal:  Nature       Date:  2012-07-04       Impact factor: 49.962

10.  Open randomised prospective comparative multi-centre intervention study of patients with cystic fibrosis and early diagnosed diabetes mellitus.

Authors:  Manfred Ballmann; Dominique Hubert; Barouk M Assael; Kai Kronfeld; Marguerite Honer; Reinhard W Holl
Journal:  BMC Pediatr       Date:  2014-03-11       Impact factor: 2.125

View more
  1 in total

1.  Oral Glucose Tolerance Test in Patients with Cystic Fibrosis Compared to the Overweight and Obese: A Different Approach in Understanding the Results.

Authors:  Mirela Mogoi; Liviu Laurentiu Pop; Mihaela Dediu; Ioana Mihaiela Ciuca
Journal:  Children (Basel)       Date:  2022-04-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.